Continuous in situ electrochemical monitoring of doxorubicin efflux from sensitive and drug-resistant cancer cells.
One of the least well understood problems in cancer chemotherapy is the cross-resistance of certain tumor cells to a series of chemically unrelated drugs. Multidrug resistance (MDR) can be attributed to several different biophysical processes, among them increased drug efflux. This has been found to correlate with overexpression of the cell surface 170-kDa P-glycoprotein that actively excludes cytotoxic drugs against their concentration gradient. To better understand MDR, experimental methods are needed to study drug efflux from cancer cells. Continuous measurement of efflux of nonfluorescent drugs on the same cell culture in situ, or assessing efflux from a few cells or even a single cell, is beyond the capabilities of existing technologies. In this work, a carbon fiber (CF) microelectrode is used to monitor efflux of doxorubicin from a monolayer of two cell lines: an auxotrophic mutant of Chinese hamster ovary cells, AUXB1, and its MDR subline, CHRC5. Because doxorubicin is both fluorescent and electroactive, the results could be validated against existing data obtained optically and with other techniques on the same cell lines, with good agreement found. The electrochemical detection, however, is capable of in situ monitoring with high temporal resolution and is suitable for single-cell studies.
Yi
C
C
Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio 44106, USA.
Gratzl
M
M
D000818:Animals; D000970:Antineoplastic Agents / Q000493:pharmacokinetics*; D016466:CHO Cells; D006224:Cricetinae; D004317:Doxorubicin / Q000493:pharmacokinetics*; D018432:Drug Resistance, Multiple / Q000502:physiology*; D004358:Drug Therapy; D004563:Electrochemistry; D006801:Humans; D008839:Microelectrodes; D015394:Molecular Structure; D009369:Neoplasms / Q000378:metabolism
D000970:Antineoplastic Agents; D004317:Doxorubicin